Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00284687 |
|
Recruitment Status :
Completed
First Posted : February 1, 2006
Last Update Posted : June 10, 2010
|
Sponsor:
Hadassah Medical Organization
Collaborators:
Institut für Klinische und Molekulare Virologie
University of Erlangen-Nürnberg Medical School
Information provided by:
Hadassah Medical Organization
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | March 2010 |
| Actual Study Completion Date : | March 2010 |